CRC Research Update — July 16, 2026
Today's colorectal cancer research highlights
ras
A collection of 50 issues
RAS mutation linked to early progression in liver metastases conversion therapy
Skip to content
The CRC Digest
RAS mutation linked to early progression in liver metastases conversion therapy
Retrospective study of 194 patients with initially unresectable, pMMR colorectal liver metastases found that RAS mutation status was associated with early progression or recurrence after conversion therapy. (Front Surg)
This content is informational
CRC Research Update — July 12, 2026
Today's colorectal cancer research highlights
RAS and BRAF status in MSI-H/dMMR metastatic CRC
Skip to content
The CRC Digest
RAS and BRAF status in MSI-H/dMMR metastatic CRC
New guidance on the role of RAS and BRAF mutations in MSI-high and dMMR metastatic colorectal cancer. (Oncodaily)
This content is informational only and does not constitute medical advice.
Always consult your oncologist or care
CRC Research Update — July 02, 2026
Today's colorectal cancer research highlights
CRC Research Update — July 01, 2026
Today's colorectal cancer research highlights
CRC Research Finding
Skip to content
The CRC Digest
▸ Multi-omics deep learning model predicts anti-EGFR therapy response in liver metastases
A multi-center study developed a deep learning framework integrating multi-omics data to predict which RAS wild-type colorectal cancer liver metastases patients will benefit from cetuximab therapy, addressing primary resistance challenges. (Curr Cancer Drug
CRC Research Update — June 25, 2026
Today's colorectal cancer research highlights
KRAS G13C Inhibitor Reveals Unique Biology of Codon 13 Mutations
Skip to content
The CRC Digest
KRAS G13C Inhibitor Reveals Unique Biology of Codon 13 Mutations
RMC-8839, a covalent KRAS G13C inhibitor, induced tumor regressions in selected xenograft models, but one-third of cell lines showed incomplete pathway suppression, revealing that codon 13-mutant RAS differs from other KRAS mutations with decreased
CRC Research Update — June 18, 2026
Today's colorectal cancer research highlights